Log on / register
Feedback | Support | My details
Open AccessResearch article

Recurring cluster and operon assembly for Phenylacetate degradation genes

Fergal J Martin email and James O McInerney email

Department of Biology, National University of Ireland Maynooth, Maynooth, Co. Kildare, Ireland

author email corresponding author email

BMC Evolutionary Biology 2009, 9:36doi:10.1186/1471-2148-9-36

Published: 10 February 2009

Abstract

Background

A large number of theories have been advanced to explain why genes involved in the same biochemical processes are often co-located in genomes. Most of these theories have been dismissed because empirical data do not match the expectations of the models. In this work we test the hypothesis that cluster formation is most likely due to a selective pressure to gradually co-localise protein products and that operon formation is not an inevitable conclusion of the process.

Results

We have selected an exemplar well-characterised biochemical pathway, the phenylacetate degradation pathway, and we show that its complex history is only compatible with a model where a selective advantage accrues from moving genes closer together. This selective pressure is likely to be reasonably weak and only twice in our dataset of 102 genomes do we see independent formation of a complete cluster containing all the catabolic genes in the pathway. Additionally, de novo clustering of genes clearly occurs repeatedly, even though recombination should result in the random dispersal of such genes in their respective genomes. Interspecies gene transfer has frequently replaced in situ copies of genes resulting in clusters that have similar content but very different evolutionary histories.

Conclusion

Our model for cluster formation in prokaryotes, therefore, consists of a two-stage selection process. The first stage is selection to move genes closer together, either because of macromolecular crowding, chromatin relaxation or transcriptional regulation pressure. This proximity opportunity sets up a separate selection for co-transcription.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.